SQZ Biotechnologies Co Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenue:
Revenue
Grant revenue
Collaboration Revenue
Total revenue
Operating expenses:
Research and development
General and administrative
Restructuring charges
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Other expense, net
Total other income, net
Reclassification adjustment for gains included in net loss, net of tax
Comprehensive loss
Net loss per share attributable to common stockholders, basic and diluted
Weighted-average common shares outstanding, basic and diluted
Net loss and comprehensive loss
Net loss per share, basic
Net loss per share, diluted
Weighted-average common shares outstanding, basic
Weighted-average common shares outstanding, diluted

Comments